Has Alan Brown, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,101 in general payments to Alan Brown, MD across 153 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alan Brown, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alan Brown, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alan Brown, MD

Ophthalmology · Wilmington, NCNPI 1649278433

Payments from drug & device makers

$10,101in general payments, 2019–2025

Across 153 payments — averaging $66.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lensar, Inc.$1K
Sanofi$1K
Alcon$1K
Rxsight Inc$1K
Johnson & Johnson Surgical Vision, Inc.$977
Bausch & Lomb Americas Inc.$793
plus $4K from 23 others

What the payments were for

Royalty or licence$701%
Speaking & faculty fees$1,29013%
Travel & lodging$120%
Food & beverage$8,69286%
Education$180%
Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lensar, Inc.	5	$1,152
Sanofi	1	$1,120
Alcon	19	$1,029
Rxsight Inc	11	$1,013
Johnson & Johnson Surgical Vision, Inc.	13	$977
Bausch & Lomb Americas Inc.	13	$793
Carl Zeiss Meditec, Inc.	9	$675
Bausch & Lomb, A Division Of Bausch Health US, LLC	14	$455
NEW World Medical,inc.	6	$416
Carl Zeiss Meditec USA, Inc.	5	$400
Quidel Corporation	3	$377
Katena Products, Inc. (dba Corza Medical)	3	$240
Sun Pharmaceutical Industries Inc.	5	$202
Eyepoint US, Inc.	2	$173
Ivantis, Inc	1	$162
Kala Pharmaceuticals, Inc.	8	$158
Ocular Therapeutix, Inc.	9	$153
Rayner Intraocular Lenses Limited	5	$104
Omeros Corporation	5	$92
Dompe US, Inc.	1	$92
Glaukos Corporation	4	$77
Harrow Eye, LLC	2	$54
Mallinckrodt Enterprises LLC	1	$35
Biotissue Holdings Inc.	2	$34
Mallinckrodt Hospital Products Inc.	1	$29
Eyevance Pharmaceuticals LLC	2	$28
Sight Sciences, Inc.	1	$23
Carl Zeiss Meditec AG	1	$19
Oyster Point Pharma, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,101 in reported general payments places this provider in the 80th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$245,743

Medicare patients

324

Services billed

1,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	125	$4,045
MoxifloxacinMoxifloxacin Hcl	66	$1,403
Ketorolac Tromethamine	62	$1,061
Tobramycin	15	$132
Potassium Chloride	12	$124

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Wilmington

Clark SpringsWilmington$300K
Leon CharkoudianWilmington$112K
Robert van der VaartWilmington$50K
Glenn JaffeDurham$38.5M
Lejla VajzovicDurham$7.5M
Andrew AntoszykCharlotte$4M
Majda HadziahmetovicDurham$2.4M
Preeya GuptaRaleigh$2M
Thomas WilliamsHickory$1.8M
James HarrisHickory$1.4M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →